Eli Lilly To Invest $364 Mln In UK's Biotech Segment To Tackle Health Challenges
14/10 17:20
(RTTNews) - Eli Lilly and Co. (LLY) is planning to invest $364 million or 279 million pounds in the biotechnology segment in the U.K., to establish Lilly Gateway Labs. The company will have its focus on Mounjaro for diabetes and Zepbound for weight loss, with a target to curb hea...